Sentiment-Signal
15,2
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
18.3
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Stammdaten
Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in Phase I/II dose escalation trial in patients with solid tumor cancers, including non-small-cell lung (NSCLC), gastric, head and neck, ovarian, and synovial sarcoma cancers; IMC-F106C, which is in a Phase I/II dose escalation trial in patients with multiple solid tumor cancers comprising NSCLC, small-cell lung, endometrial, ovarian, cutaneous melanoma, and breast cancers. In addition, the company's programs for infectious diseases include IMC-I109V, which is in a Phase I/II clinical trial in patients with chronic hepatitis B virus; and IMC-M113V that is in pre-clinical development stage for patients with human immunosuppression virus. Further, it develops product candidates to provide precision targeted immunosuppression for the treatment of autoimmune diseases. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom.
Unternehmen & Branche
| Name | Immunocore Holdings plc |
|---|---|
| Ticker | IMCR |
| CIK | 0001671927 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2836 · Biological Products, (No Diagnostic Substances) |
Wertpapier & Kennzahlen
| CUSIP | 45258D105 |
|---|---|
| ISIN | US45258D1054 |
| Typ | ADR |
| Marktkapitalisierung | 1,61 Mrd. USD |
| Beta | 0,83 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 400,016,000 | -35,514,000 | -0.71 | 1,067,269,000 | 381,033,000 |
| 2025-09-30 | 10-Q | 103,693,000 | -177,000 | 0.00 | 1,102,500,000 | 396,564,000 |
| 2025-06-30 | 10-Q | 97,964,000 | -10,300,000 | -0.20 | 1,082,387,000 | 388,481,000 |
| 2025-03-31 | 10-Q | 93,881,000 | 5,023,000 | 0.10 | 1,028,008,000 | 378,479,000 |
| 2024-12-31 | 10-K | 310,202,000 | -51,087,000 | -1.02 | 1,009,506,000 | 360,716,000 |
| 2024-09-30 | 10-Q | 80,248,000 | 8,736,000 | 0.17 | 1,084,638,000 | 377,827,000 |
| 2024-06-30 | 10-Q | 75,400,000 | -11,616,000 | -0.23 | 1,023,365,000 | 359,137,000 |
| 2024-03-31 | 10-Q | 70,502,000 | -24,436,000 | -0.49 | 993,987,000 | 359,534,000 |
| 2023-12-31 | 10-K | 249,428,000 | -55,287,000 | -1.13 | 597,001,000 | 368,843,000 |
| 2023-09-30 | 10-Q | 64,850,000 | 906,000 | 0.02 | 355,970,000 | |
| 2023-06-30 | 10-Q | 59,757,000 | -17,014,000 | -0.35 | 351,440,000 | |
| 2023-03-31 | 10-Q | 54,659,000 | -19,449,000 | -0.40 | 341,304,000 | |
| 2022-12-31 | 10-K | 174,361,000 | -52,543,000 | -1.15 | 526,762,000 | 338,903,000 |
| 2021-12-31 | 10-K | 36,484,000 | -180,029,000 | -4.24 | 233,705,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 32,770,643 | 0 | 32,770,643 | 188,554,823 | Neu | +100,0% | |
| RTW INVESTMENTS, LP | 4,869,798 | 0 | 4,869,798 | 169,030,689 | Neu | +100,0% | |
| FMR LLC | 4,539,225 | 0 | 4,539,225 | 157,556,482 | Neu | +100,0% | |
| PRIMECAP MANAGEMENT CO/CA/ | 3,961,880 | 0 | 3,961,880 | 137,516,856 | Neu | +100,0% | |
| BAKER BROS. ADVISORS LP | 2,322,656 | 0 | 2,322,656 | 80,619,390 | Neu | +100,0% | |
| Deep Track Capital, LP | 2,003,978 | 0 | 2,003,978 | 69,558,076 | Neu | +100,0% | |
| Context Capital Management, LLC | 71,541,000 | 0 | 71,541,000 | 65,012,884 | Neu | +100,0% | |
| Fiera Capital Corp | 1,044,831 | 0 | 1,044,831 | 36,266,084 | Neu | +100,0% | |
| CAMDEN ASSET MANAGEMENT L P /CA | 36,235,000 | 0 | 36,235,000 | 32,747,381 | Neu | +100,0% | |
| MILLENNIUM MANAGEMENT LLC | 911,597 | 0 | 911,597 | 31,641,532 | Neu | +100,0% | |
| Kynam Capital Management, LP | 856,462 | 0 | 856,462 | 29,727,796 | Neu | +100,0% | |
| PRINCIPAL FINANCIAL GROUP INC | 658,436 | 0 | 658,436 | 22,854,314 | Neu | +100,0% | |
| Kohlberg Kravis Roberts & Co. L.P. | 23,385,000 | 0 | 23,385,000 | 21,251,119 | Neu | +100,0% | |
| Vestal Point Capital, LP | 585,000 | 0 | 585,000 | 20,305,350 | Neu | +100,0% | |
| FRANKLIN RESOURCES INC | 20,000,000 | 0 | 20,000,000 | 18,175,000 | Neu | +100,0% | |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 20,000,000 | 0 | 20,000,000 | 18,075,000 | Neu | +100,0% | |
| BlackRock, Inc. | 5,354,099 | 0 | 5,354,099 | 15,964,371 | Neu | +100,0% | |
| JANUS HENDERSON GROUP PLC | 454,404 | 0 | 454,404 | 15,733,739 | Neu | +100,0% | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 407,404 | 0 | 407,404 | 14,140,993 | Neu | +100,0% | |
| Frazier Life Sciences Management, L.P. | 384,782 | 0 | 384,782 | 13,355,783 | Neu | +100,0% | |
| Hudson Bay Capital Management LP | 383,558 | 0 | 383,558 | 13,313,298 | Neu | +100,0% | |
| TWO SIGMA INVESTMENTS, LP | 359,293 | 0 | 359,293 | 12,471,060 | Neu | +100,0% | |
| STATE STREET CORP | 8,879,556 | 0 | 8,879,556 | 11,262,125 | Neu | +100,0% | |
| MORGAN STANLEY | 287,125 | 0 | 287,125 | 9,966,126 | Neu | +100,0% | |
| Candriam S.C.A. | 269,729 | 0 | 269,729 | 9,362,692 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 242,168 | 0 | 242,168 | 8,405,651 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 234,737 | 0 | 234,737 | 8,147,723 | Neu | +100,0% | |
| WOLVERINE ASSET MANAGEMENT LLC | 8,012,800 | 0 | 8,012,800 | 7,682,725 | Neu | +100,0% | |
| NEW YORK STATE COMMON RETIREMENT FUND | 211,140 | 0 | 211,140 | 7,328,669 | Neu | +100,0% | |
| D. E. Shaw & Co., Inc. | 183,940 | 0 | 183,940 | 6,384,557 | Neu | +100,0% | |
| Legal & General Group Plc | 149,333 | 0 | 149,333 | 5,183,349 | Neu | +100,0% | |
| ADVENT CAPITAL MANAGEMENT /DE/ | 5,600,000 | 0 | 5,600,000 | 5,147,722 | Neu | +100,0% | |
| RENAISSANCE TECHNOLOGIES LLC | 140,900 | 0 | 140,900 | 4,890,639 | Neu | +100,0% | |
| AMERIPRISE FINANCIAL INC | 135,207 | 0 | 135,207 | 4,693,036 | Neu | +100,0% | |
| JANE STREET GROUP, LLC | 122,640 | 0 | 122,640 | 4,256,835 | Neu | +100,0% | |
| Caption Management, LLC | 119,384 | 0 | 119,384 | 4,143,819 | Neu | +100,0% | |
| Wellesley Asset Management | 4,150,000 | 0 | 4,150,000 | 3,744,358 | Neu | +100,0% | |
| BARCLAYS PLC | 103,253 | 0 | 103,253 | 3,583,912 | Neu | +100,0% | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 85,169 | 0 | 85,169 | 2,909,209 | Neu | +100,0% | |
| WELLS FARGO & COMPANY/MN | 96,228 | 0 | 96,228 | 2,697,819 | Neu | +100,0% | |
| CITIGROUP INC | 319,900 | 0 | 319,900 | 2,212,685 | Neu | +100,0% | |
| MARSHALL WACE, LLP | 61,163 | 0 | 61,163 | 2,122,968 | Neu | +100,0% | |
| JPMORGAN CHASE & CO | 2,187,699 | 0 | 2,187,699 | 2,109,521 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 60,188 | 0 | 60,188 | 2,089,125 | Neu | +100,0% | |
| SEI INVESTMENTS CO | 50,337 | 0 | 50,337 | 1,747,194 | Neu | +100,0% | |
| Nicholas Investment Partners, LP | 1,900,000 | 0 | 1,900,000 | 1,717,125 | Neu | +100,0% | |
| Y-Intercept (Hong Kong) Ltd | 48,187 | 0 | 48,187 | 1,672,571 | Neu | +100,0% | |
| TUDOR INVESTMENT CORP ET AL | 44,231 | 0 | 44,231 | 1,535,258 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 43,026 | 0 | 43,026 | 1,493,432 | Neu | +100,0% | |
| ROYAL BANK OF CANADA | 42,486 | 0 | 42,486 | 1,475,000 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-02-18 | Berman David M | Officer, HEAD OF R&D | Open Market Sale | -5,965 | 32.35 | -192,967.75 | -31,3% | |
| 2026-02-18 | St Leger Tina Amber | Officer, CHIEF HR OFFICER | Open Market Sale | -1,000 | 32.35 | -32,350.00 | -5,3% | |
| 2026-02-18 | GOLL JOHN | Officer, SVP, FINANCE & CAO | Open Market Sale | -698 | 32.35 | -22,580.30 | -3,7% | |
| 2026-02-18 | Jallal Bahija | Director, Officer, CHIEF EXECUTIVE OFFICER | Open Market Sale | -11,474 | 32.35 | -371,183.90 | -60,3% | |
| 2025-12-05 | Berman David M | Officer, HEAD OF R&D | Open Market Sale | -572 | 40.14 | -22,960.08 | -3,7% | |
| 2025-12-04 | Berman David M | Officer, HEAD OF R&D | Open Market Sale | -31,341 | 40.26 | -1,261,788.66 | -204,8% | |
| 2025-11-28 | Berman David M | Officer, HEAD OF R&D | Open Market Sale | -5,521 | 40.09 | -221,336.89 | -35,9% | |
| 2025-11-26 | Berman David M | Officer, HEAD OF R&D | Open Market Sale | -69,404 | 40.12 | -2,784,488.48 | -452,0% | |
| 2025-11-25 | Berman David M | Officer, HEAD OF R&D | Open Market Sale | -18,020 | 40.03 | -721,340.60 | -117,1% | |
| 2025-11-24 | Berman David M | Officer, HEAD OF R&D | Open Market Sale | -100 | 40.00 | -4,000.00 | -0,6% | |
| 2025-09-30 | Berman David M | Officer, HEAD OF R&D | Open Market Sale | -61,849 | 35.23 | -2,178,940.27 | -353,7% | |
| 2025-09-15 | Berman David M | Officer, HEAD OF R&D | Open Market Sale | -200 | 35.01 | -7,002.00 | -1,1% | |
| 2025-09-12 | Berman David M | Officer, HEAD OF R&D | Open Market Sale | -1,300 | 36.31 | -47,203.00 | -7,7% | |
| 2025-09-12 | Berman David M | Officer, HEAD OF R&D | Open Market Sale | -21,232 | 35.63 | -756,496.16 | -122,8% |
Fail-to-Deliver (6 Monate)
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-03-18 | 429 | 30,73 | 13.183 |
| 2026-03-17 | 1.155 | 30,57 | 35.308 |
| 2026-03-16 | 563 | 30,86 | 17.374 |
| 2026-03-10 | 2.140 | 33,41 | 71.497 |
| 2026-03-09 | 102 | 32,94 | 3.360 |
| 2026-03-03 | 36 | 32,67 | 1.176 |
| 2026-03-02 | 372 | 32,30 | 12.016 |
| 2026-02-27 | 71 | 32,04 | 2.275 |
| 2026-02-26 | 26 | 32,16 | 836 |
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | 32,770,643 | 188,554,823 | 14.15 |
| RTW INVESTMENTS, LP | 4,869,798 | 169,030,689 | 12.68 |
| FMR LLC | 4,539,225 | 157,556,482 | 11.82 |
| PRIMECAP MANAGEMENT CO/CA/ | 3,961,880 | 137,516,856 | 10.32 |
| BAKER BROS. ADVISORS LP | 2,322,656 | 80,619,390 | 6.05 |
| Deep Track Capital, LP | 2,003,978 | 69,558,076 | 5.22 |
| Context Capital Management, LLC | 71,541,000 | 65,012,884 | 4.88 |
| Fiera Capital Corp | 1,044,831 | 36,266,084 | 2.72 |
| CAMDEN ASSET MANAGEMENT L P /CA | 36,235,000 | 32,747,381 | 2.46 |
| MILLENNIUM MANAGEMENT LLC | 911,597 | 31,641,532 | 2.37 |
| Kynam Capital Management, LP | 856,462 | 29,727,796 | 2.23 |
| PRINCIPAL FINANCIAL GROUP INC | 658,436 | 22,854,314 | 1.71 |
| Kohlberg Kravis Roberts & Co. L.P. | 23,385,000 | 21,251,119 | 1.59 |
| Vestal Point Capital, LP | 585,000 | 20,305,350 | 1.52 |
| FRANKLIN RESOURCES INC | 20,000,000 | 18,175,000 | 1.36 |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 20,000,000 | 18,075,000 | 1.36 |
| BlackRock, Inc. | 5,354,099 | 15,964,371 | 1.20 |
| JANUS HENDERSON GROUP PLC | 454,404 | 15,733,739 | 1.18 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 407,404 | 14,140,993 | 1.06 |
| Frazier Life Sciences Management, L.P. | 384,782 | 13,355,783 | 1.00 |